非洲真菌病流行病学:诊断驱动因素综述。

Q3 Medicine Current Medical Mycology Pub Date : 2021-03-01 DOI:10.18502/cmm.7.1.6246
Felix Bongomin, Samuel Adetona Fayemiwo
{"title":"非洲真菌病流行病学:诊断驱动因素综述。","authors":"Felix Bongomin,&nbsp;Samuel Adetona Fayemiwo","doi":"10.18502/cmm.7.1.6246","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>There has been a significant increase in the burden of fungal diseases in the last few decades which has imposed a global threat to the health of humans, animals, and plants. Epidemiology of fungal diseases is not completely understood in Africa. Most of these diseases are under-reported or not reported at all mainly due to the challenges related to the availability of and access to fungal diagnostics and the lack of human resources in clinical and diagnostic mycology across the continent. Therefore, it is imperative to highlight the epidemiology of the endemic and epidemic of emerging and re-emerging fungal diseases as well as their diagnostic challenges in Africa based on the available data. Moreover, it is important to underline the existing gaps in this regard as well.</p><p><strong>Materials and methods: </strong>For the purposes of the study, Medline and Google Scholar were searched to retrieve articles on these prominent fungal diseases, as well as their etiologies and available diagnostics.</p><p><strong>Results: </strong>It was found that histoplasmosis and other AIDS-associated mycoses have been reported in Africa, including blastomycosis, coccidioidomycosis, and paracocci-dioidomycosis. Other reported infections were fungal neglected tropical diseases, especially sporotrichosis, dermatophytosis, mycetoma, and chromoblastomycosis as well as emerging fungal diseases, such as <i>Emergomyces africanus</i>, <i>Candida auris</i>, and <i>Blastomyces emzantsi</i>. In Africa, the major drivers of fungal diseases include human immunodeficiency infection, tuberculosis, and poverty.</p><p><strong>Conclusion: </strong>Serious fungal diseases are common in Africa; however, the true burden remains unknown.</p>","PeriodicalId":10863,"journal":{"name":"Current Medical Mycology","volume":"7 1","pages":"63-70"},"PeriodicalIF":0.0000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443876/pdf/","citationCount":"10","resultStr":"{\"title\":\"Epidemiology of fungal diseases in Africa: A review of diagnostic drivers.\",\"authors\":\"Felix Bongomin,&nbsp;Samuel Adetona Fayemiwo\",\"doi\":\"10.18502/cmm.7.1.6246\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and purpose: </strong>There has been a significant increase in the burden of fungal diseases in the last few decades which has imposed a global threat to the health of humans, animals, and plants. Epidemiology of fungal diseases is not completely understood in Africa. Most of these diseases are under-reported or not reported at all mainly due to the challenges related to the availability of and access to fungal diagnostics and the lack of human resources in clinical and diagnostic mycology across the continent. Therefore, it is imperative to highlight the epidemiology of the endemic and epidemic of emerging and re-emerging fungal diseases as well as their diagnostic challenges in Africa based on the available data. Moreover, it is important to underline the existing gaps in this regard as well.</p><p><strong>Materials and methods: </strong>For the purposes of the study, Medline and Google Scholar were searched to retrieve articles on these prominent fungal diseases, as well as their etiologies and available diagnostics.</p><p><strong>Results: </strong>It was found that histoplasmosis and other AIDS-associated mycoses have been reported in Africa, including blastomycosis, coccidioidomycosis, and paracocci-dioidomycosis. Other reported infections were fungal neglected tropical diseases, especially sporotrichosis, dermatophytosis, mycetoma, and chromoblastomycosis as well as emerging fungal diseases, such as <i>Emergomyces africanus</i>, <i>Candida auris</i>, and <i>Blastomyces emzantsi</i>. In Africa, the major drivers of fungal diseases include human immunodeficiency infection, tuberculosis, and poverty.</p><p><strong>Conclusion: </strong>Serious fungal diseases are common in Africa; however, the true burden remains unknown.</p>\",\"PeriodicalId\":10863,\"journal\":{\"name\":\"Current Medical Mycology\",\"volume\":\"7 1\",\"pages\":\"63-70\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443876/pdf/\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Medical Mycology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18502/cmm.7.1.6246\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Medical Mycology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/cmm.7.1.6246","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 10

摘要

背景和目的:在过去的几十年里,真菌疾病的负担显著增加,对人类、动物和植物的健康构成了全球性的威胁。真菌病的流行病学在非洲尚未完全了解。大多数这些疾病的报告不足或根本没有报告,主要原因是与真菌诊断的可得性和可及性以及整个非洲大陆缺乏临床和诊断真菌学方面的人力资源有关的挑战。因此,必须根据现有数据,强调非洲新出现和再出现的真菌病的地方性和流行病的流行病学,以及它们在诊断方面的挑战。此外,还必须强调这方面的现有差距。材料和方法:为了本研究的目的,我们检索了Medline和Google Scholar,检索了关于这些突出真菌疾病的文章,以及它们的病因和可用的诊断方法。结果:在非洲有组织浆菌病和其他与艾滋病相关的真菌病的报道,包括芽孢菌病、球孢子菌病和副球孢子菌病。其他报告的感染是真菌被忽视的热带病,特别是孢子菌病、皮肤真菌病、足菌肿和成色菌病,以及新出现的真菌疾病,如非洲新兴菌、耳念珠菌和emzantsi芽孢菌。在非洲,真菌疾病的主要驱动因素包括人类免疫缺陷感染、结核病和贫困。结论:严重真菌病在非洲较为常见;然而,真正的负担仍然未知。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Epidemiology of fungal diseases in Africa: A review of diagnostic drivers.

Background and purpose: There has been a significant increase in the burden of fungal diseases in the last few decades which has imposed a global threat to the health of humans, animals, and plants. Epidemiology of fungal diseases is not completely understood in Africa. Most of these diseases are under-reported or not reported at all mainly due to the challenges related to the availability of and access to fungal diagnostics and the lack of human resources in clinical and diagnostic mycology across the continent. Therefore, it is imperative to highlight the epidemiology of the endemic and epidemic of emerging and re-emerging fungal diseases as well as their diagnostic challenges in Africa based on the available data. Moreover, it is important to underline the existing gaps in this regard as well.

Materials and methods: For the purposes of the study, Medline and Google Scholar were searched to retrieve articles on these prominent fungal diseases, as well as their etiologies and available diagnostics.

Results: It was found that histoplasmosis and other AIDS-associated mycoses have been reported in Africa, including blastomycosis, coccidioidomycosis, and paracocci-dioidomycosis. Other reported infections were fungal neglected tropical diseases, especially sporotrichosis, dermatophytosis, mycetoma, and chromoblastomycosis as well as emerging fungal diseases, such as Emergomyces africanus, Candida auris, and Blastomyces emzantsi. In Africa, the major drivers of fungal diseases include human immunodeficiency infection, tuberculosis, and poverty.

Conclusion: Serious fungal diseases are common in Africa; however, the true burden remains unknown.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current Medical Mycology
Current Medical Mycology Medicine-Infectious Diseases
CiteScore
2.10
自引率
0.00%
发文量
16
审稿时长
4 weeks
期刊最新文献
Effect of yeast probiotic Saccharomyces boulardii cell wall extract on Aspergillus fumigatus allergenicity in A549 cells. Enhanced in-vitro anti-Candida efficacy of Euphorbia milii Des Moul mediated copper nanoparticles against clinically isolated Candida albicans. Evaluation of exoenzyme profiles of Candida albicans species isolated from females with vaginal candidiasis. Candida auris in a tertiary healthcare setting in south India: A case series. In vitro antifungal activity of biosynthesized selenium nanoparticles using plant extracts and six comparators against clinical Fusarium strains.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1